Trials / Unknown
UnknownNCT02704299
The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.
A Single-centered Clinical Trial of Surgery，Chemotherapy in Combination With Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer.
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Shanghai AbelZeta Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the feasibility ,safety and efficacy of Surgery，Chemotherapy in Combination with Autologous T cells-Based Immunotherapy for Advanced Gastric Cancer.
Detailed description
Safety:AE/SAE Efficacy:immunologic function;FPS
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous T cells-Based Immunotherapy | TCM cells are the subpopulation of T lymphocytes with key characteristics including high potency and long-term memory of specific immunity. |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2018-06-01
- Completion
- 2018-09-01
- First posted
- 2016-03-10
- Last updated
- 2016-03-11
Source: ClinicalTrials.gov record NCT02704299. Inclusion in this directory is not an endorsement.